https://edgen.pre.edgen.tech/news/post/major-companies-reconsider-ai-costs-as-chipmaker-surge-fuels-bubble-debate2026-05-31T16:39:27.726Zdaily1Edgen Stocken2026-05-31T16:39:27.726+00:00Major companies reconsider AI costs as chipmaker surge fuels bubble debatehttps://static.edgen.tech/news/images/major-companies-reconsider-ai-costs-as-chipmaker-surge-fuels-bubble-debate-20260531.pngMajor companies reconsider AI costs as chipmaker surge fuels bubble debate https://edgen.pre.edgen.tech/news/post/nxp-semiconductors-rallies-8-as-auto-demand-and-data-center-sales-improve2026-05-31T16:11:40.190Zdaily1Edgen Stocken2026-05-31T16:11:40.190+00:00NXP Semiconductors rallies 8% as auto demand and data center sales improvehttps://static.edgen.tech/news/images/nxp-semiconductors-rallies-8-as-auto-demand-and-data-center-sales-improve-20260531.pngNXP Semiconductors rallies 8% as auto demand and data center sales improve https://edgen.pre.edgen.tech/news/post/bond-market-bets-on-ai-to-solve-36-trillion-inflation-puzzle2026-05-31T16:10:55.844Zdaily1Edgen Stocken2026-05-31T16:10:55.844+00:00Bond market bets on AI to solve $36 trillion inflation puzzlehttps://static.edgen.tech/news/images/bond-market-bets-on-ai-to-solve-36-trillion-inflation-puzzle-20260531.pngBond market bets on AI to solve $36 trillion inflation puzzle https://edgen.pre.edgen.tech/news/post/spacexs-285-trillion-tam-claim-draws-scrutiny-as-ipo-nears2026-05-31T16:10:07.501Zdaily1Edgen Stocken2026-05-31T16:10:07.501+00:00SpaceX's $28.5 trillion TAM claim draws scrutiny as IPO nearshttps://static.edgen.tech/news/images/spacexs-285-trillion-tam-claim-draws-scrutiny-as-ipo-nears-20260531.pngSpaceX's $28.5 trillion TAM claim draws scrutiny as IPO nears https://edgen.pre.edgen.tech/news/post/data-center-land-grab-creates-3-investment-plays-for-ai-buildout2026-05-31T15:39:32.646Zdaily1Edgen Stocken2026-05-31T15:39:32.646+00:00Data center land grab creates 3 investment plays for AI buildouthttps://static.edgen.tech/news/images/data-center-land-grab-creates-3-investment-plays-for-ai-buildout-20260531.pngData center land grab creates 3 investment plays for AI buildout https://edgen.pre.edgen.tech/news/post/quantum-computing-etfs-surge-45-as-chips-act-unlocks-2-billion2026-05-31T15:39:24.598Zdaily1Edgen Stocken2026-05-31T15:39:24.598+00:00Quantum computing ETFs surge 45% as CHIPS Act unlocks $2 billionhttps://static.edgen.tech/news/images/quantum-computing-etfs-surge-45-as-chips-act-unlocks-2-billion-20260531.pngQuantum computing ETFs surge 45% as CHIPS Act unlocks $2 billion https://edgen.pre.edgen.tech/news/post/may-jobs-report-and-5-earnings-reports-to-drive-markets-this-week2026-05-31T15:09:42.989Zdaily1Edgen Stocken2026-05-31T15:09:42.989+00:00May jobs report and 5 earnings reports to drive markets this weekhttps://static.edgen.tech/news/images/may-jobs-report-and-5-earnings-reports-to-drive-markets-this-week-20260531.pngMay jobs report and 5 earnings reports to drive markets this week https://edgen.pre.edgen.tech/news/post/booz-allen-ceo-warns-chinese-ai-models-pose-3-national-security-threats2026-05-31T14:40:41.362Zdaily1Edgen Stocken2026-05-31T14:40:41.362+00:00Booz Allen CEO warns Chinese AI models pose 3 national security threatshttps://static.edgen.tech/news/images/booz-allen-ceo-warns-chinese-ai-models-pose-3-national-security-threats-20260531.pngBooz Allen CEO warns Chinese AI models pose 3 national security threats https://edgen.pre.edgen.tech/news/post/jjs-rybrevant-faspro-posts-42-response-rate-in-head-and-neck-cancer2026-05-31T14:10:09.337Zdaily1Edgen Stocken2026-05-31T14:10:09.337+00:00J&J's RYBREVANT FASPRO posts 42% response rate in head and neck cancerhttps://static.edgen.tech/news/images/jjs-rybrevant-faspro-posts-42-response-rate-in-head-and-neck-cancer-20260531.pngJ&J's RYBREVANT FASPRO posts 42% response rate in head and neck cancer https://edgen.pre.edgen.tech/news/post/iran-removes-nuclear-issue-from-talks-raising-oil-risk-premium2026-05-31T14:09:40.862Zdaily1Edgen Stocken2026-05-31T14:09:40.862+00:00Iran removes nuclear issue from talks, raising oil risk premiumhttps://static.edgen.tech/news/images/iran-removes-nuclear-issue-from-talks-raising-oil-risk-premium-20260531.pngIran removes nuclear issue from talks, raising oil risk premium https://edgen.pre.edgen.tech/news/post/jjs-erleada-cuts-metastasis-risk-by-20-in-prostate-cancer-trial2026-05-31T12:39:27.867Zdaily1Edgen Stocken2026-05-31T12:39:27.867+00:00J&J's Erleada cuts metastasis risk by 20% in prostate cancer trialhttps://static.edgen.tech/news/images/jjs-erleada-cuts-metastasis-risk-by-20-in-prostate-cancer-trial-20260531.pngJ&J's Erleada cuts metastasis risk by 20% in prostate cancer trial https://edgen.pre.edgen.tech/news/post/daraxonrasib-cuts-death-risk-60-in-pancreatic-cancer-trial2026-05-31T12:39:23.880Zdaily1Edgen Stocken2026-05-31T12:39:23.880+00:00Daraxonrasib cuts death risk 60% in pancreatic cancer trialhttps://static.edgen.tech/news/images/daraxonrasib-cuts-death-risk-60-in-pancreatic-cancer-trial-20260531.pngDaraxonrasib cuts death risk 60% in pancreatic cancer trial https://edgen.pre.edgen.tech/news/post/pfizer-braftovi-regimen-nearly-doubles-pfs-in-braf-v600e-mcrc-trial2026-05-31T12:14:33.866Zdaily1Edgen Stocken2026-05-31T12:14:33.866+00:00Pfizer BRAFTOVI regimen nearly doubles PFS in BRAF V600E mCRC trialhttps://static.edgen.tech/news/images/pfizer-braftovi-regimen-nearly-doubles-pfs-in-braf-v600e-mcrc-trial-20260531.pngPfizer BRAFTOVI regimen nearly doubles PFS in BRAF V600E mCRC trial https://edgen.pre.edgen.tech/news/post/goldman-sachs-flags-extreme-greed-with-5-overheating-metrics2026-05-31T12:10:35.557Zdaily1Edgen Stocken2026-05-31T12:10:35.557+00:00Goldman Sachs flags extreme greed with 5 overheating metricshttps://static.edgen.tech/news/images/goldman-sachs-flags-extreme-greed-with-5-overheating-metrics-20260531.pngGoldman Sachs flags extreme greed with 5 overheating metrics https://edgen.pre.edgen.tech/news/post/johnson-johnson-meets-2-primary-endpoints-in-phase-3-prostate-cancer-trial2026-05-31T12:10:02.464Zdaily1Edgen Stocken2026-05-31T12:10:02.464+00:00Johnson & Johnson meets 2 primary endpoints in Phase 3 prostate cancer trialhttps://static.edgen.tech/news/images/johnson-johnson-meets-2-primary-endpoints-in-phase-3-prostate-cancer-trial-20260531.pngJohnson & Johnson meets 2 primary endpoints in Phase 3 prostate cancer trial https://edgen.pre.edgen.tech/news/post/ivonescimab-cuts-death-risk-34-in-lung-cancer-trial-challenging-keytruda2026-05-31T12:09:44.132Zdaily1Edgen Stocken2026-05-31T12:09:44.132+00:00Ivonescimab cuts death risk 34% in lung cancer trial, challenging Keytrudahttps://static.edgen.tech/news/images/ivonescimab-cuts-death-risk-34-in-lung-cancer-trial-challenging-keytruda-20260531.pngIvonescimab cuts death risk 34% in lung cancer trial, challenging Keytruda https://edgen.pre.edgen.tech/news/post/jensen-huang-calls-humanoid-robots-a-40-trillion-market-heres-why-wall-street-buys-in2026-05-31T11:39:19.136Zdaily1Edgen Stocken2026-05-31T11:39:19.136+00:00Jensen Huang calls humanoid robots a $40 trillion market — here's why Wall Street buys inhttps://static.edgen.tech/news/images/jensen-huang-calls-humanoid-robots-a-40-trillion-market-heres-why-wall-street-buys-in-20260531.pngJensen Huang calls humanoid robots a $40 trillion market — here's why Wall Street buys in https://edgen.pre.edgen.tech/news/post/warsh-urges-fed-to-adopt-2-inflation-gauges-showing-lower-prices2026-05-31T10:09:30.454Zdaily1Edgen Stocken2026-05-31T10:09:30.454+00:00Warsh urges Fed to adopt 2 inflation gauges showing lower priceshttps://static.edgen.tech/news/images/warsh-urges-fed-to-adopt-2-inflation-gauges-showing-lower-prices-20260531.pngWarsh urges Fed to adopt 2 inflation gauges showing lower prices https://edgen.pre.edgen.tech/news/post/trumps-perfect-4th-cognitive-test-score-fuels-mandatory-screening-push2026-05-31T09:09:58.251Zdaily1Edgen Stocken2026-05-31T09:09:58.251+00:00Trump's perfect 4th cognitive test score fuels mandatory screening pushhttps://static.edgen.tech/news/images/trumps-perfect-4th-cognitive-test-score-fuels-mandatory-screening-push-20260531.pngTrump's perfect 4th cognitive test score fuels mandatory screening push https://edgen.pre.edgen.tech/news/post/match-group-says-tinder-turnaround-gains-traction-as-hinge-grows-282026-05-31T07:41:26.674Zdaily1Edgen Stocken2026-05-31T07:41:26.674+00:00Match Group says Tinder turnaround gains traction as Hinge grows 28%https://static.edgen.tech/news/images/match-group-says-tinder-turnaround-gains-traction-as-hinge-grows-28-20260531.pngMatch Group says Tinder turnaround gains traction as Hinge grows 28%